• Evaluation of the mindray CL900i CLIA HIV Ag/Ab combo assay for sensitive and specific HIV screening compared to established methods. 

      K Nasrallah, Gheyath; Younes, Nadin; Khalid, Hadiya M; Al-Emadi, Jawaher A; Younes, Salma; ... more authors ( Springer Nature , 2024 , Article)
      Architect-HIV Ag/Ab combo chemiluminescence assay is globally recognized for its sensitivity but has a notable false-positive rate. In this study, we aim to evaluate the performance of a new cost-effective screening ...
    • Expression profile of MicroRNA: An Emerging Hallmark of Cancer. 

      Zaheer, Uzma; Faheem, Muhammed; Qadri, Ishtiaq; Begum, Nargis; Yassine, Hadi M; ... more authors ( Bentham Science Publishers , 2019 , Article Review)
      MicroRNA (miRNAs), a class of small, endogenous non-coding RNA molecules of about 21-24 nucleotides in length, have unraveled a new modulatory network of RNAs that form an additional level of post-transcriptional gene ...
    • Hepatitis E Viruses : Emerging and Transboundary Animal Viruses 

      Kumar, Harsh; Kamar, Nassim; Nasrallah, Gheyath K.; Kumar, Dinesh ( Springer , 2020 , Book chapter)
      Hepatitis E virus (HEV), member of genus Orthohepevirus in the family Hepeviridae, is the leading cause of hepatitis E. More than 20 million cases of hepatitis E virus (HEV) infection have been reported globally, out of ...
    • Non-coding RNAs as biomarkers of myocardial infarction 

      Almaghrbi, Heba; Giordo, Roberta; Pintus, Gianfranco; Zayed, Hatem ( Elsevier , 2023 , Article)
      Non-coding RNAs (ncRNAs) encompass a family of ubiquitous RNA molecules that lack protein-coding potential and have tissue-specific expression. A significant body of evidence indicates that ncRNA's aberrant expression plays ...
    • The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers 

      Mestiri, Sarra; El-Ella, Dina Moustafa Abo; Fernandes, Queenie; Bedhiafi, Takwa; Almoghrabi, Salam; ... more authors ( Elsevier , 2024 , Article Review)
      Head and neck cancer (HNC) is the sixth most common cancer type, accounting for approximately 277,597 deaths worldwide. Recently, the Food and Drug Administration (FDA) has approved immune checkpoint blockade (ICB) agents ...